Pharmacologic inhibition of lipogenesis for the treatment of NAFLD is a research paper published in Journal of Hepatology (2023). On theSindex it has a DataRank of 0.698. It has been cited 104 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.698
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK056626
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK103046
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01 DK133988
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R37DK048873
NIDDK NIH HHS
Grant: R01 DK048873
National Institutes of Health
MeSH Terms
Keywords